Alignment Healthcare (ALHC) Expected to Announce Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) will likely be releasing its earnings data after the market closes on Thursday, February 27th. Analysts expect Alignment Healthcare to post earnings of ($0.18) per share and revenue of $675.62 million for the quarter. Persons that wish to register for the company's earnings conference call can do so using this link.

Alignment Healthcare Trading Down 8.4 %

Shares of Alignment Healthcare stock traded down $1.21 on Friday, hitting $13.17. The stock had a trading volume of 2,613,574 shares, compared to its average volume of 1,797,702. The stock has a 50 day moving average of $13.19 and a 200 day moving average of $11.76. Alignment Healthcare has a twelve month low of $4.46 and a twelve month high of $15.82. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market capitalization of $2.52 billion, a P/E ratio of -17.10 and a beta of 1.50.

Insiders Place Their Bets

In other news, COO Sebastian Burzacchi sold 8,550 shares of the company's stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total transaction of $96,273.00. Following the transaction, the chief operating officer now directly owns 217,395 shares of the company's stock, valued at $2,447,867.70. This represents a 3.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total value of $411,600.00. Following the transaction, the president now directly owns 1,576,097 shares in the company, valued at $21,624,050.84. The trade was a 1.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 476,002 shares of company stock worth $6,220,726. Corporate insiders own 6.60% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ALHC. Stifel Nicolaus upped their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the company a "buy" rating in a research note on Tuesday, January 14th. Barclays upped their target price on Alignment Healthcare from $7.00 to $8.00 and gave the company an "underweight" rating in a report on Wednesday, October 30th. Stephens reiterated an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd. Finally, UBS Group upped their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.